Capivast 200 mg (Capivasertib) contains capivasertib, an AKT inhibitor used with endocrine therapy to treat certain HR-positive, HER2-negative advanced or metastatic breast cancers with specific genetic alterations. It blocks cancer cell growth signals, helping slow disease progression. Treatment should be prescribed and monitored by an experienced oncologist. https://oncologymedi.com/product/capivast-200-mg-capivasertib/